Thiobutabarbital

Template:Short description Template:Short description Template:Template other{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =

| _has_physiological_data= | _has_gene_therapy=

| vaccine_type= | mab_type= | _number_of_combo_chemicals= | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=101622O=C1NC(=S)NC(=O)C1(C(C)CC)CC1S/C10H16N2O2S/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15)IDELNEDBPWKHGK-UHFFFAOYSA-NTemplate:StdinchiciteTemplate:Stdinchicite | _combo_data= | _physiological_data= | _clinical_data= none | _legal_data=

| _other_data=5-sec-butyl-5-ethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione

| _image_0_or_2 = Thiobutabarbital Structure.svg | _image_LR =

| _datapage = Thiobutabarbital (data page) | _vaccine_target=_type_not_vaccine | _legal_all= | _ATC_prefix_supplemental=none | _has_EMA_link = | CAS_number=2095-57-0 | PubChem=3032373 | ChemSpiderID=2297366 | ChEBI= | ChEMBL= | DrugBank= | KEGG= | _hasInChI_or_Key=yes | UNII=2N0251U7JH | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =

| _countSecondIDs= | _countIndexlabels= | _trackListSortletter= |QID = |QID2 = |Verifiedfields=changed |Watchedfields= |verifiedrevid=470606909}}

Thiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia.

Stereochemistry

Thiobutabarbital contains a stereocenter and consists of two enantiomers. This is a racemate, i.e. a 1:1 mixture of (R)- and the (S)-form:

Enantiomers of Thiobutabarbital
File:(R)-Thiobutabarbital Structural Formula V1.svg (R)-Form	File:(S)-Thiobutabarbital Structural Formula V1.svg (S)-Form

References

Template:Asbox